Literature DB >> 2858448

Direct versus indirect pressor and vasoconstrictor actions of angiotensin in conscious dogs.

A M Fujii, S F Vatner.   

Abstract

To determine the importance of the direct and the indirect pressor and vasoconstrictor actions of angiotensin II (ANG II), experiments were conducted in conscious dogs 2 to 8 weeks after instrumentation with aortic catheters and aortic electromagnetic flow probes to measure arterial pressure and cardiac output. Total peripheral resistance was calculated by an on-line digital computer. Pretreatment with propranolol eliminated complicating inotropic effects of norepinephrine, released by the indirect actions of ANG II. The pressor and vasoconstrictor responses after ganglionic blockade, in either the presence or absence of arterial baroreceptor nerves, were considered to be the direct effects of ANG II. In conscious dogs, systemically administered ANG II (32 ng/kg bolus) increased mean arterial pressure by 38 +/- 3 mm Hg, total peripheral resistance by 37 +/- 2 mm Hg/L/minute, and decreased heart rate by 15 +/- 2 beats/minute. After arterial baroreceptor denervation, administration of ANG II increased mean arterial pressure by 88 +/- 7 mm Hg, total peripheral resistance by 54 +/- 4 mm Hg/L/minute, and heart rate by 12 +/- 2 beats/minute. After arterial baroreceptor denervation and ganglionic blockade with hexamethonium, administration of ANG II increased mean arterial pressure by 53 +/- 8 mm Hg, total peripheral resistance by 27 +/- 3 mm Hg/L/minute, and left heart rate unchanged. These results indicate that in the conscious dog without baroreflex buffering nearly one-half of the pressor and vasoconstrictor actions of angiotensin are not direct, but are mediated by the autonomic nervous system.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2858448     DOI: 10.1161/01.hyp.7.2.253

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  4 in total

1.  TRPV1 (Transient Receptor Potential Vanilloid 1) Cardiac Spinal Afferents Contribute to Hypertension in Spontaneous Hypertensive Rat.

Authors:  Julia Shanks; Sharon D B de Morais; Lie Gao; Irving H Zucker; Han-Jun Wang
Journal:  Hypertension       Date:  2019-08-19       Impact factor: 10.190

2.  Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277.

Authors:  W Wienen; N Hauel; J C Van Meel; B Narr; U Ries; M Entzeroth
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

3.  The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure.

Authors:  Christophe Guilluy; Jérémy Brégeon; Gilles Toumaniantz; Malvyne Rolli-Derkinderen; Kevin Retailleau; Laurent Loufrani; Daniel Henrion; Elizabeth Scalbert; Antoine Bril; Raul M Torres; Stephan Offermanns; Pierre Pacaud; Gervaise Loirand
Journal:  Nat Med       Date:  2010-01-24       Impact factor: 53.440

4.  Effects of exposure to simulated microgravity on neuronal catecholamine release and blood pressure responses to norepinephrine and angiotensin.

Authors:  V A Convertino; D A Ludwig; B D Gray; J Vernikos
Journal:  Clin Auton Res       Date:  1998-04       Impact factor: 4.435

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.